← Latest briefing

Health

Fox News reports researchers test artificial intelligence tools across medical fields

Fox News reports that medical institutions are developing artificial intelligence tools for cancer, fertility, and disease tracking.

The short version

  • Medical institutions and researchers are testing various artificial intelligence technologies across specialized fields including oncology, drug repurposing, fertility care, and disease risk estimation.[Fox News]
  • Developments include personalized cancer vaccine trials, microfluidic sperm tracking systems, and deep learning algorithms designed to assess long-term cardiovascular risks.[Fox News]
  • Many featured clinical applications, algorithms, and investigational drugs remain subject to ongoing trials and regulatory reviews before potential widespread adoption.[Fox News]

Key facts

  • Moderna and Merck announced positive topline Phase 3 melanoma trial results on August 19 for intismeran autogene combined with Keytruda.[Fox News]
  • Every Cure uses AI to scan biomedical literature and generate connections identifying potential new uses for existing approved drugs.[Fox News]
  • Columbia University Fertility Center's STAR system analyzes high-speed imaging to identify sperm, recording its first reported pregnancy in March 2025.[Fox News]
  • University of Hong Kong researchers designed CardiOmicScore using deep learning on blood molecular data to estimate future risk for six cardiovascular diseases.[Fox News]

What remains uncertain

  • Intismeran autogene remains investigational and has not received FDA approval for melanoma treatment.[Fox News]
  • No voice-derived endpoint for tracking ALS or Parkinson's disease progression has received regulatory qualification from the FDA or European Medicines Agency.[Fox News]

Sources

Outlet counts describe coverage, not independent confirmation. Reports may share a wire service or original source.